Skip to Main Content

Advertisement intended for health care professionals

American Society of Hematology Logo Open Menu
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 9, Issue 15
August 12 2025
Blood Advances Cover Image for Volume 9, Issue 15

Table of Contents

INSIDE BLOOD ADVANCES

Exorcizing the devil of factor VIII inhibitors
Paul C. Moorehead
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
ESCALATing care? Eltrombopag in pediatric aplastic anemia
Clinical Trials & Observations
Joshua Glass,Emma M. Groarke
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Biomarker signatures for sickle cell pain
Clinical Trials & Observations
Kalpna Gupta,Vidhya Kumaresan
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
The balancing act after pediatric venous thromboembolism
Hilary Whitworth,Leslie Raffini
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Targeting PD-1 for HCT relapse: an immunologic knife’s edge
Clinical Trials & Observations
Roman M. Shapiro,Robert J. Soiffer
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

ADVANCES VIEWPOINT

To pursue gene therapy or not? Is it feasible after graft failure in allogeneic hematopoietic cell transplant recipients
Akshay Sharma,Tami John
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

REVIEW ARTICLES

Advancements in complement inhibition for PNH and primary complement–mediated thrombotic microangiopathy
Clinical Trials & Observations
Thalia Padilla Kelley,Hannah King,Aditya Malhotra,Thomas G. DeLoughery,Kylee Martens,Joseph J. Shatzel
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Blinatumomab use in pediatric B-ALL: where are we now?
Anurekha G. Hall,Rachel E. Rau
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

CLINICAL TRIALS AND OBSERVATIONS

Long-term follow-up of MRD-guided ibrutinib plus venetoclax in relapsed CLL: phase 2 VISION/HO141 trial
Clinical Trials & Observations
Carsten U. Niemann,Julie Dubois,Kazem Nasserinejad,Caspar da Cunha-Bang,Sabina Kersting,Lisbeth Enggaard,Gerrit J. Veldhuis,Rogier Mous,Clemens H.M. Mellink,Anne-Marie F. van der Kevie-Kersemaekers,Johan A. Dobber,Christian B. Poulsen,Wida Razawy,René Hollestein,Henrik Frederiksen,Ann Janssens,Ida Schjødt,Ellen C. Dompeling,Juha Ranti,Christian Brieghel,Mattias Mattsson,Mar Bellido,Hoa T. T. Tran,Arnon P. Kater,Mark-David Levin
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Lisocabtagene maraleucel for R/R LBCL in patients not intended for HSCT: final results of the phase 2 PILOT study
Clinical Trials & Observations
Alison Sehgal,Daanish Hoda,Peter A. Riedell,Nilanjan Ghosh,Mehdi Hamadani,Gerhard C. Hildebrandt,John E. Godwin,Patrick M. Reagan,Nina D. Wagner-Johnston,James Essell,Rajneesh Nath,Scott R. Solomon,Rebecca Champion,Edward Licitra,Suzanne Fanning,Neel K. Gupta,Victor A. Chow,Brenda Yuan,Zhi Yang,Ken Ogasawara,Jerill Thorpe,Leo I. Gordon
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Eltrombopag in combination with immunosuppressive therapy in pediatric severe aplastic anemia: phase 2 ESCALATE trial
Clinical Trials & Observations
Akiko Shimamura,Alexey Maschan,Carolyn Bennett,Sujith Samarasinghe,Jason E. Farrar,Chi-kong Li,Nongnuch Sirachainan,Bunchoo Pongtanakul,Patcharee Komvilaisak,Ludmila Zubarovskaya,Jennifer A. Rothman,Kelly Walkovich,Taizo A. Nakano,Alison A. Bertuch,Anabela Ferrao,Rukhmi Bhat,Rabi Hanna,Kathleen Overholt,Jessica Boklan,Tze Fang Wong,Qinxia Wang,Patrick Urban,Brigitte Strahm,Winfred Wang,Adrianna Vlachos,David A. Williams
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
ESCALATing care? Eltrombopag in pediatric aplastic anemia
Clinical Trials & Observations
Joshua Glass,Emma M. Groarke
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Gut microbiota restoration with oral pooled fecal microbiotherapy after intensive chemotherapy: the phase 1b CIMON trial
Clinical Trials & Observations
Florent Malard,Sylvain Thepot,Thomas Cluzeau,Martin Carré,Delphine Lebon,Pierre Bories,Ollivier Legrand,Marianne Schwarz,Michael Loschi,Mathieu Meunier,Magalie Joris,Cyrielle Gasc,Juliette Jouve,Benoît Levast,Emilie Plantamura,Emmanuel Prestat,Antoine Sabourin,Béatrice Gaugler,Joel Dore,Christian Récher,Mohamad Mohty
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Molecular inflammatory expression profiles associated with the frequency of pain in individuals with sickle cell disease
Clinical Trials & Observations
Lana Mucalo Katunaric,Shuang Jia,Ashima Singh,Mark F. Roethle,Julie A. Panepinto,David C. Brousseau,Martin J. Hessner,Amanda M. Brandow
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Biomarker signatures for sickle cell pain
Clinical Trials & Observations
Kalpna Gupta,Vidhya Kumaresan
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Real-world survival outcomes in first-line ibrutinib-treated patients with high-risk CLL/SLL
Clinical Trials & Observations
John N. Allan,Tao Ran,Zhijie Ding,Jinghua He,Alex Bokun,Zaina P. Qureshi,Susan M. O’Brien
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

HEALTH SERVICES AND OUTCOMES

Inaccuracies of venous thromboembolism risk assessment and prevention practices among medically ill patients
Brandyn D. Lau,Aditya Bhave,Jennifer C. Yui,Rakhi Naik,Kathryn E. Dane,John Lindsley,Dauryne L. Shaffer,Peggy S. Kraus,Erik H. Hoyer,Elliott R. Haut,Michael B. Streiff
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

HEMATOPOIESIS AND STEM CELLS

The SAMD1 transcription factor coordinates hematopoietic lineage differentiation and H3K4 methylation status
Meg A. Schaefer,Samantha L. Gomez,Venkatasai Rahul Dogiparthi,Yichao Zhou,Pooja Roy,Suhita Ray,Linda Chee,Sandipan Brahma,Robert Liefke,Kyle J. Hewitt
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
BCLAF1 restrains stress responses in hematopoietic stem cells to support expansion and repopulation
Stephanie J. Crowley,Wei Yang,Lynn S. White,Jun Wu,Yanan Li,Haley Schmidt,Kyunghee Choi,Jeffrey A. Magee,Jeffrey J. Bednarski
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

LYMPHOID NEOPLASIA

Genetic deregulation of REL in germinal center B cells induces generation of a pool of lymphoma precursor cells
Léa Prévaud,Karima Ferhat,Dilara Sensoy,Ophélie Téteau,Tiffany Marchiol,Quentin Lemasson,Catherine Ouk,Claire Carrion,Michel Cogné,Jean Feuillard,Christelle Vincent-Fabert,Nathalie Faumont
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Indirect comparison of epcoritamab vs chemoimmunotherapy, mosunetuzumab, or odronextamab in follicular lymphoma
Alexey V. Danilov,Swetha Kambhampati Thiruvengadam,Kim Linton,Karen Cumings,Viktor Chirikov,Alex Mutebi,Savreet Bains Chawla,Anindit Chhibber,Fernando Rivas Navarro,Felipe Marques Gonçalves,Anthony Wang,Zhijie Ding,Abualbishr Alshreef,Elena Favaro,Daniela Hoehn,Anna Sureda
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Safety and efficacy of glofitamab for relapsed/refractory large B-cell lymphoma in a multinational real-world study
Clinical Trials & Observations
Evgenii Shumilov,Rebecca Wurm-Kuczera,Andrea Kerkhoff,Meng Wang,Thomas Melchardt,Udo Holtick,Ulrike Bacher,Philipp Staber,Paolo Mazzeo,Corinna Leng,David Böckle,Alexander Hölscher,Joseph Kauer,Natalia Rotter,Vladan Vucinic,Jakob Rudzki,David Nachbaur,Veit Bücklein,Ulf Schnetzke,Isabelle Krämer,Kai Wille,Alexander Hasse,Bastian von Tresckow,Mathias Hänel,Christian Koenecke,Giuliano Filippini Velazquez,Andreas Viardot,Christoph Schmid,Lorenz Thurner,Dominik Wolf,Marion Subklewe,Martin Dreyling,Peter Dreger,Sascha Dietrich,Ulrich Keller,Ulrich Jäger,Richard Greil,Thomas Pabst,Georg Lenz,Björn Chapuy
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Extramedullary plasmacytoma in children is a genetically distinct localized neoplasia curable by surgical resection
Ilske Oschlies,Julia Richter,Amelie Alfert,Fernando Chahud,Stephanie Mueller,Ingrid Simonitsch-Klupp,Hannah von Mersi,Andishe Attarbaschi,Karoline Koch,Christoph Schaefers,Monika Brüggemann,Cecilia Bozzetti,Wilhelm Woessmann,Birgit Burkhardt,Wolfram Klapper
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma
Evgenii Shumilov,Julia Katharina Scholz,Maximilian Seib,Paolo Mazzeo,Rebecca Wurm-Kuczera,Vladan Vucinic,Udo Holtick,Hristo Boyadzhiev,Thomas Melchardt,Alexander Hölscher,Christian Schultze-Florey,Atef Abdelhafez,Giuliano Filippini Velazquez,Anna Ossami Saidy,Vadim Lesan,Ulf Schnetzke,Andrea Kerkhoff,Ulrike Bacher,Susanne Ghandili,Enver Aydilek,Niklas Gebauer,Thomas Weber,Gerald Wulf,Bertram Glass,Lorenz Thurner,Florian H. Heidel,Christoph Schmid,Andreas Viardot,Mathias Hänel,Sascha Dietrich,Thomas Pabst,Francis Ayuk,Bastian von Tresckow,Björn Chapuy,Christiane Pott,Fabian Müller,Georg Lenz
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Pralatrexate is effective in cytotoxic cutaneous T-cell lymphomas
Christina Poh,Jenna M. Voutsinas,Mazyar Shadman,Ryan C. Lynch,Edus H. Warren,Caitlin A. Crimp,Brian G. Till,Chaitra S. Ujjani,Mengyang Di,Vikram Raghunathan,Stephen D. Smith,Qian V. Wu,Michi M. Shinohara,Ajay K. Gopal
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Thyroid hormones contribute to JAK/STAT pathway abnormal activation, promoting T-cell lymphoma dissemination
Mercedes Debernardi,Alejandro Correa,Lucero Alvarado,María Victoria Revuelta,Helena Andrea Sterle,Gonzalo Gonzalez,Ingrid Larissa Melo Souza,Jorgelina Real,María Teresa Garcia de Dávila,Johanna Abigail Díaz Albuja,Cinthia Rosemblit,Leandro Cerchietti,Graciela Alicia Cremaschi,Florencia Cayrol
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

MYELOID NEOPLASIA

Real-world effectiveness of immunoglobulin replacement for hypogammaglobulinemia and infections in multiple myeloma
Elizabeth O’Donnell,Thais Gift,Zaid Yousif,Nikhil Khandelwal,Raj Desai,Lynn Huynh,Louise Clear,Megan Pinaire,Mingchen Ye,Azeem Banatwala,Gregory Belsky,Yichuan Grace Hsieh,Christopher Herrick,Mei Sheng Duh,Shawn N. Murphy,Marie Sanchirico
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
A revised prognostic model for patients with acute myeloid leukemia and first relapse
Niek G. van der Maas,Dimitri Breems,Clara P. W. Klerk,Thomas Pabst,Patrycja Gradowska,Abin Thomas,Bart J. Biemond,Jurgen Kuball,Catharina H. M. J. Van Elssen,Otto Visser,Marie-Christiane Vekemans,Carlos Graux,Johan Maertens,Steven Knapper,Mike Dennis,Sylvie Freeman,Ian Thomas,H. Berna Beverloo,Gerwin Huls,Charles Craddock,Peter J. M. Valk,Paresh Vyas,Nigel Russell,Gert Ossenkoppele,Bob Löwenberg,Jan J. Cornelissen,Jurjen Versluis
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Clec12a is required for the pathogenesis of NUP98::NSD1 AML
Sagarajit Mohanty,Fiorella Charles Cano,Razif Gabdoulline,Courteney K. Lai,Basem Othman,Harish Sudarsanam,Thomas Eder,Florian Grebien,Daniel B. Lipka,Reinhard Henschler,Michael Heuser
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

PLASMA CELL DISORDERS

Predictive value of free light chain burden in patients with AL amyloidosis treated with bortezomib-based regimens
Brendan Saunders,Foteini Theodorakakou,Despina Fotiou,Samuel Boullt,Benjamin Evans,Meletios A. Dimopoulos,Efstathios Kastritis,Giada Bianchi
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Extramedullary myeloma is genomically complex and characterized by near-universal MAPK pathway alterations
Saurabh Zanwar,Joseph Novak,Wilson Gonsalves,Michael Howe,Esteban Braggio,S. Vincent Rajkumar,Moritz Binder,Dragan Jevremovic,Surendra Dasari,Shaji Kumar
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Outcomes in frail patients receiving BCMA-directed bispecific antibodies for relapsed/refractory multiple myeloma
Benjamin Adegbite,Carlyn Rose Tan,Tala Shekarkhand,Ross S. Firestone,Eric M. Jurgens,Kevin Miller,Alexander M. Lesokhin,Gunjan L. Shah,Neha Korde,Sridevi Rajeeve,Heather J. Landau,Michael Scordo,Hani Hassoun,Kylee H. Maclachlan,Urvi A. Shah,Malin Hultcrantz,Issam S. Hamadeh,Andriy Derkach,David Nemirovsky,Sergio A. Giralt,Sham Mailankody,Saad Z. Usmani,Hamza Hashmi
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

RED CELLS, IRON, AND ERYTHROPOIESIS

PRIDE-FTG advances academic careers of underrepresented early-stage investigators performing blood disorders research
Betty S. Pace,Oluwatoyosi A. Onwuemene,Athena Starlard-Davenport,Rhea-Beth Markowitz,Vahé Heboyan,Petar Datsov,Treva Rice
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Use of the microfluidic impedance red cell assay in sickle cell disease
Clinical Trials & Observations
Akshay A. Patwardhan,Ashwin Patel,Abhinav Pasupuleti,Solomon Oshabaheebwa,Christopher A. Delianides,Zoe Sekyonda,Justin J. Yoo,Jonathan Wade,Erica Evans,Michael A. Suster,Pedram Mohseni,Umut A. Gurkan,Vivien A. Sheehan
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

THROMBOSIS AND HEMOSTASIS

Patient anti-FVIII drug antibodies bind preferentially to a subset of FVIII covalent states
Diego Butera,Aster E. Pijning,Nathan G. Avery,Carmen H. Coxon,Clive Metcalfe,Angelina Mimoun,Sébastien Lacroix-Desmazes,Paul Clint Spiegel, Jr.,Philip J. Hogg
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Exorcizing the devil of factor VIII inhibitors
Paul C. Moorehead
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
A global survey on practice changes and barriers to the use of direct oral anticoagulants in children
M. Laura Avila,Erica Di Ruggiero,Jennifer Vincelli,Leonardo R. Brandão
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Recurrent thrombosis and major bleeding in children treated for VTE
Stephanie F. Lenahan,Anne Blackmore,Matthew Fenchel,Evan Thomas,Joseph S. Palumbo,Cristina Tarango
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
The balancing act after pediatric venous thromboembolism
Hilary Whitworth,Leslie Raffini
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
The CLUE postsurgery VTE risk instrument for abdominal and pelvic surgery: validation of patient risk factor component
Clinical Trials & Observations
Kari A. O. Tikkinen,Deborah M. Siegal,P. J. Devereaux,Sara V. Tornberg,Flavia K. Borges,Sandra Ofori,Jehonathan Pinthus,Bobby Shayegan,Lauri I. Lavikainen,Gordon H. Guyatt,Pavel S. Roshanov
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Single-cell sequencing on PBMCs from patients with HA and HB with inhibitors reveals different immune responses to FVIII and FIX
Enhao Li,Zekun Li,Jinzeng Wang,Haoyang Wu,Yilun Xue,Can Lou,Zhenping Chen,Feng Liu,Wenman Wu,Qiulan Ding,Runhui Wu,Xuefeng Wang,Jing Dai
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

TRANSPLANTATION

PD-1 inhibition for relapse after allogeneic transplantation in acute myeloid leukemia and myelodysplastic syndrome
Clinical Trials & Observations
John M. Magenau,David G. Frame,Mary Riwes,John Maciejewski,Sarah Anand,Attaphol Pawarode,Anamarija M. Perry,Marcus Geer,Thomas Braun,Monalisa Ghosh,Pavan Reddy
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Targeting PD-1 for HCT relapse: an immunologic knife’s edge
Clinical Trials & Observations
Roman M. Shapiro,Robert J. Soiffer
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Outcomes of haploidentical vs mismatched unrelated donor HCT with posttransplant cyclophosphamide prophylaxis
Yosra M. Aljawai,Jeremy Ramdial,Gabriela Rondon,Portia Smallbone,Partow Kebriaei,Uday Popat,Betul Oran,Katayoun Rezvani,Richard E. Champlin,Elizabeth J. Shpall,Rohtesh S. Mehta
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

RESEARCH LETTERS

T-cell dysfunction during blinatumomab therapy in pediatric acute lymphoblastic leukemia
Julie Ma,Annie Luong,Andrew Doan,Tsen Yin Lin,Lingyun Ji,Cassandra P. Wang,Seon-Jae Yoon,Teresa Rushing,Anh Duong,Miguel Villa,Chintan Parekh
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Brentuximab vedotin and nivolumab for untreated patients with Hodgkin lymphoma: long-term results
Clinical Trials & Observations
Bruce D. Cheson,Nancy L. Bartlett,Betsy Knopf,Hun J. Lee,Ranjana H. Advani,Beth Christian,Catherine S. Diefenbach,Tatyana A. Feldman,Stephen M. Ansell
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Dysregulated immune proteins in plasma in the UK Biobank predict multiple myeloma 12 years before clinical diagnosis
Joshua Fieggen,Anshul Thakur,Christopher C. Butler,Karthik Ramasamy,Anjan Thakurta,David A. Clifton,Lei Clifton
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Drug development for leukemia: comprehensive analysis of clinical trials from first report to drug approval
Clinical Trials & Observations
Kellen Cristine Tjioe,Marisol Miranda-Galvis,Kenza Mamouni,Thalyta Freitas,Muhannad Sharara,Brenda Santellano,Claudia Guillén-Lopez,Jorge E. Cortes
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
RAS mutation identifies a poor prognostic molecular subtype of therapy-related myeloid neoplasm
Chung Hoow Kok,Aref Al-Kali,Daniel Thomas,Rong He,Monika M. Kutyna,Hassan Alkhateeb,Kelly Lim,Antoine N. Saliba,Carla Toop,Aasiya Matin,Hamish Scott,Naseema Gangat,Anna Brown,Abhishek Mangaonkar,Christopher N. Hahn,Kebede Begna,Kevin Hung,Patricia Greipp,William J. Hogan,Mrinal Patnaik,Mithun Shah,Devendra K. Hiwase
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Fatal recurrence of IEC-HS after autologous stem cell boost in patients receiving BCMA-CAR T-cell therapy
Snegha Ananth,Nancy Eunice Torres,Bita Sahaf,Lekha Mikkilineni,Sebastian Fernandez-Pol,Darren Salmi,Robert Negrin,Parveen Shiraz,Melody Smith,Sushma Bharadwaj,Wen-Kai Weng,Vanessa E. Kennedy,Saurabh Dahiya,Lori Muffly,David Miklos,Matthew J. Frank,Hitomi Hosoya,Surbhi Sidana
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Molecular profiling of primary renal diffuse large B-cell lymphoma unravels a proclivity for immune-privileged tropism
Axel Künstner,Vera von Kopylow,Philipp Lohneis,Matthias Kümmel,Hanno M. Witte,Lorenz Bastian,Veronica Bernard,Stephanie Stölting,Kathrin Kusch,Nikolas von Bubnoff,Konrad Steinestel,Annette Arndt,Hartmut Merz,Hauke Busch,Alfred C. Feller,Niklas Gebauer
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

LETTERS TO THE EDITOR

Interpretation of response in BOS: the definitions remain key
Clinical Trials & Observations
Kirsten M. Williams,Vibha Lama,Kenneth R. Cooke,Gregory A. Yanik
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Conflating polycythemia vera with essential thrombocytosis
Clinical Trials & Observations
Jerry L. Spivak
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Frontline allo-SCT in MRD-negative, intermediate-risk AML
Eduardo Rodríguez-Arbolí,Teresa Caballero-Velázquez,Cristina Marrero-Cepeda,José Antonio Pérez-Simón
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

RESPONSE

Integrating MRD kinetics with allogeneic SCT decisions in AML
Wei-Ying Jen,Nicholas J. Short
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
  • Cover Image

    Cover Image

    issue cover

    Fluorescence staining of germinal center on a spleen section from a REL–activation-induced cytidine deaminase dual color mouse model. The DAPI, YFP, and tdTomato (TOM) fluorescence was colorized in blue, green, and red, respectively. The fluorescence of the germinal center marker peanut agglutinin (PNA) was colorized in white. The image shows the merged fluorescence for DAPI/PNA/TOM/YFP. See the article by Prévaud et al.

All Issues

Advertisement intended for health care professionals

Asciminib for relapsed or refractory Philadelphia chromosome–positive acute lymphoblastic leukemia
National Alliance of Sickle Cell Centers consensus standards for transition to adult care in sickle cell disease
Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenström macroglobulinemia
Efficacy and safety of BCMA nanobody CAR T-cell therapy in relapsed or refractory plasma cell myeloma
Deleting ACC1 in platelets alters phospholipidome and reduces platelet activation and thrombosis in mice

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2025 by American Society of Hematology
 
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals